These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Mediastinal and osseous lymphangiomatosis: case report and review. Watts MA; Gibbons JA; Aaron BL Ann Thorac Surg; 1982 Sep; 34(3):324-8. PubMed ID: 7114951 [No Abstract] [Full Text] [Related]
11. Lymphangioma-like Kaposi's sarcoma with gastric involvement in a patient with lung cancer. Kalambokis G; Kitsanou M; Stergiopoulou C; Zioga A; Dimou S; Tsianos EV J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):653-4. PubMed ID: 16164738 [No Abstract] [Full Text] [Related]
12. Human epidermal growth factor receptor 2 testing in breast cancer: 30% versus 10% cutoff for immunohistochemistry. Hameed O; Chhieng D; Adams AL J Clin Oncol; 2008 Mar; 26(9):1571. PubMed ID: 18349417 [No Abstract] [Full Text] [Related]
13. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077 [TBL] [Abstract][Full Text] [Related]
14. [Systemic hemangiomatosis and lymphangiomatosis]. Kostov M; Tatić V; Cerović S; Skatarić V; Bjelajac D Vojnosanit Pregl; 1997; 54(4):391-3. PubMed ID: 9441510 [No Abstract] [Full Text] [Related]
15. Sudden death of a 14-year-old girl with lymphangiomatosis. Nakagawa T; Koizumi T; Oiwa K; Inomoto C; Ogura G; Masuda R; Yamashita T; Nakamura N; Iwazaki M Gen Thorac Cardiovasc Surg; 2016 Feb; 64(2):116-9. PubMed ID: 25047633 [TBL] [Abstract][Full Text] [Related]
19. [Epidermal growth factor receptor as a prognostic factor of breast cancers]. Tsutsui S Nihon Rinsho; 2000 Apr; 58 Suppl():442-7. PubMed ID: 11026031 [No Abstract] [Full Text] [Related]
20. Gefitinib in pretreated non-small-cell lung cancer (NSCLC): analysis of efficacy and correlation with HER2 and epidermal growth factor receptor expression in locally advanced or metastatic NSCLC. Cappuzzo F; Gregorc V; Rossi E; Cancellieri A; Magrini E; Paties CT; Ceresoli G; Lombardo L; Bartolini S; Calandri C; de Rosa M; Villa E; Crino L J Clin Oncol; 2003 Jul; 21(14):2658-63. PubMed ID: 12860941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]